Vahid Lohrasbi

655 total citations
19 papers, 467 citations indexed

About

Vahid Lohrasbi is a scholar working on Molecular Biology, Food Science and Infectious Diseases. According to data from OpenAlex, Vahid Lohrasbi has authored 19 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Food Science and 7 papers in Infectious Diseases. Recurrent topics in Vahid Lohrasbi's work include Probiotics and Fermented Foods (6 papers), Gut microbiota and health (6 papers) and Brucella: diagnosis, epidemiology, treatment (3 papers). Vahid Lohrasbi is often cited by papers focused on Probiotics and Fermented Foods (6 papers), Gut microbiota and health (6 papers) and Brucella: diagnosis, epidemiology, treatment (3 papers). Vahid Lohrasbi collaborates with scholars based in Iran, France and Italy. Vahid Lohrasbi's co-authors include Abed Zahedi Bialvaei, Arezoo Asadi, Nima Mohammadzadeh, Marcela Krůtová, Mansour Sedighi, Abolfazl Amini, Michael R. Hamblin, Elnaz Ohadi, Taghi Amiriani and Ebrahim Kouhsari and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Biological Macromolecules and Clinical Nutrition.

In The Last Decade

Vahid Lohrasbi

19 papers receiving 460 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vahid Lohrasbi Iran 11 201 128 115 88 69 19 467
Atieh Yaghoubi Iran 12 172 0.9× 108 0.8× 129 1.1× 91 1.0× 31 0.4× 33 489
Michael Reck Germany 15 446 2.2× 53 0.4× 143 1.2× 57 0.6× 58 0.8× 21 826
Johannes Putze Germany 8 270 1.3× 45 0.4× 72 0.6× 20 0.2× 54 0.8× 9 521
Kristin Surmann Germany 15 329 1.6× 34 0.3× 196 1.7× 26 0.3× 35 0.5× 42 602
Christian Fermér Sweden 14 208 1.0× 44 0.3× 202 1.8× 50 0.6× 148 2.1× 26 717
Arunima Mishra United States 12 348 1.7× 52 0.4× 60 0.5× 14 0.2× 46 0.7× 22 652
Qiwen Hu China 14 396 2.0× 45 0.4× 405 3.5× 31 0.4× 24 0.3× 24 642
Marc A. B. Kolkman Netherlands 12 237 1.2× 83 0.6× 71 0.6× 24 0.3× 32 0.5× 15 589
Joanna M. Marshall United States 9 177 0.9× 49 0.4× 190 1.7× 20 0.2× 403 5.8× 16 647

Countries citing papers authored by Vahid Lohrasbi

Since Specialization
Citations

This map shows the geographic impact of Vahid Lohrasbi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vahid Lohrasbi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vahid Lohrasbi more than expected).

Fields of papers citing papers by Vahid Lohrasbi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vahid Lohrasbi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vahid Lohrasbi. The network helps show where Vahid Lohrasbi may publish in the future.

Co-authorship network of co-authors of Vahid Lohrasbi

This figure shows the co-authorship network connecting the top 25 collaborators of Vahid Lohrasbi. A scholar is included among the top collaborators of Vahid Lohrasbi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vahid Lohrasbi. Vahid Lohrasbi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Lohrasbi, Vahid, Milad Abdi, Shiva Mirkalantari, et al.. (2022). The probiotic properties and potential of vaginal Lactobacillus spp. isolated from healthy women against some vaginal pathogens. Letters in Applied Microbiology. 74(5). 752–764. 12 indexed citations
2.
Razavi, Shabnam, et al.. (2021). Antibiotic Susceptibility Pattern and Distribution of Virulence Factors Among Klebsiella pneumoniae Isolated from Healthy Volunteers. Iranian Journal of Medical Microbiology. 15(6). 676–683. 2 indexed citations
3.
Abdi, Milad, Vahid Lohrasbi, Arezoo Asadi, et al.. (2021). Interesting probiotic traits of mother's milk Lactobacillus isolates; from bacteriocin to inflammatory bowel disease improvement. Microbial Pathogenesis. 158. 104998–104998. 20 indexed citations
4.
Darbandi, Atieh, Roya Ghanavati, Arezoo Asadi, et al.. (2021). Prevalence of bacteriocin genes in Lactobacillus strains isolated from fecal samples of healthy individuals and their inhibitory effect against foodborne pathogens.. SHILAP Revista de lepidopterología. 24(8). 1117–1125. 5 indexed citations
5.
Lohrasbi, Vahid, et al.. (2021). Analysis of virulence genes and molecular typing of Listeria monocytogenes isolates from human, food, and livestock from 2008 to 2016 in Iran. Tropical Animal Health and Production. 53(1). 127–127. 2 indexed citations
6.
Mohammadzadeh, Nima, et al.. (2020). A glance at the prevalence of coronavirus disease 19 (COVID-19) in Iran: Strengths and weaknesses. Infection Control and Hospital Epidemiology. 41(12). 1479–1482. 10 indexed citations
7.
Lohrasbi, Vahid, et al.. (2020). Brief outcome of five decades of battle with infectious diseases in Iran. VirusDisease. 31(1). 10–12. 2 indexed citations
8.
Abdi, Milad, Rasoul Mirzaei, Vahid Lohrasbi, & Khosrow Zamani. (2020). Zagros Mountains: A region in Iran with extremely high incidence of Brucellosis. Infection Control and Hospital Epidemiology. 41(3). 380–382. 4 indexed citations
9.
Lohrasbi, Vahid, et al.. (2020). Persister cells formation and expression of type II Toxin-Antitoxin system genes in Brucella melitensis (16M) and Brucella abortus (B19). Iranian journal of pathology. 15(2). 127–133. 18 indexed citations
10.
Lohrasbi, Vahid, Milad Abdi, Arezoo Asadi, et al.. (2020). The effect of improved formulation of chitosan-alginate microcapsules of Bifidobacteria on serum lipid profiles in mice. Microbial Pathogenesis. 149. 104585–104585. 18 indexed citations
11.
Kalani, Behrooz Sadeghi, et al.. (2020). The expression of type II TA system genes following exposure to the sub-inhibitory concentration of gentamicin and acid stress in Brucella spp.. Microbial Pathogenesis. 144. 104194–104194. 12 indexed citations
12.
13.
Talebi, Malihe, Javad Sadeghi, Ali Ahmadi, et al.. (2019). High Rate of Serotype Switching and Genetic Variations Indicates Widespread Recombination Between Clinical and Commensal Penicillin-Nonsusceptible Streptococcus pneumoniae in Tehran. Microbial Drug Resistance. 25(6). 865–873. 4 indexed citations
14.
Darbandi, Atieh, et al.. (2019). The effects of probiotics on reducing the colorectal cancer surgery complications: A periodic review during 2007–2017. Clinical Nutrition. 39(8). 2358–2367. 38 indexed citations
15.
Haghi, Fakhri, Vahid Lohrasbi, & Habib Zeighami. (2019). High incidence of virulence determinants, aminoglycoside and vancomycin resistance in enterococci isolated from hospitalized patients in Northwest Iran. BMC Infectious Diseases. 19(1). 744–744. 43 indexed citations
16.
Sedighi, Mansour, Abed Zahedi Bialvaei, Michael R. Hamblin, et al.. (2019). Therapeutic bacteria to combat cancer; current advances, challenges, and opportunities. Cancer Medicine. 8(6). 3167–3181. 205 indexed citations
17.
Khoshnood, Saeed, Mohsen Heidary, Mehri Haeili, et al.. (2018). Novel vaccine candidates against Mycobacterium tuberculosis. International Journal of Biological Macromolecules. 120(Pt A). 180–188. 30 indexed citations
18.
Lohrasbi, Vahid, et al.. (2018). Overview development and applications of CRISPR-Cas systems after a decade of research with a glance at anti-CRISPR proteins. Reviews in Medical Microbiology. 30(1). 47–55. 1 indexed citations
19.
Lohrasbi, Vahid, Malihe Talebi, Abed Zahedi Bialvaei, et al.. (2017). Trends in the discovery of new drugs for Mycobacterium tuberculosis therapy with a glance at resistance. Tuberculosis. 109. 17–27. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026